Meeting
2017 ASCO Annual Meeting
Molecular profiling of advanced pancreatic cancer (PC) patients from a phase I/II study using circulating tumor DNA.
Authors
Daniel V.T. Catenacci
University of Chicago Pritzker School of Medicine, Chicago, IL
Daniel V.T. Catenacci , Emma Green , Michael Epstein , Greg Jones , Clive D. Morris , Emily O'Day , S Lomnicki , Melissa Maranto , Theodore G. Karrison , Hedy L. Kindler
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 35, 2017 (suppl; abstr 4124)
DOI
10.1200/JCO.2017.35.15_suppl.4124
Abstract #
4124
Poster Bd #
116
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Clinical outcomes analysis of TP53-mutated advanced and metastatic biliary tract cancers.
First Author: Sunyoung S. Lee
Poster
2018 ASCO Annual Meeting
Real-time circulating tumor DNA profiling of advanced cholangiocarcinoma (CCA).
First Author: Kabir Mody
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Characterizing outcomes of ERBB2-amplified biliary tract cancer.
First Author: Daniel Aaron Fox
Poster
2023 ASCO Annual Meeting
Real-world (RW) outcomes of patients (pts) with advanced breast cancer (aBC) with and without resistance alterations (alts) detected in cell-free circulating tumor DNA (ctDNA) prior to CDK4/6 inhibitor (CDK4/6i) plus endocrine therapy (ET) treatment.
First Author: Seth Andrew Wander